Perianal Hyperhidrosis Successfully Treated with Botulinum Toxin A

2021 ◽  
pp. 1-4
Author(s):  
Leandra Reguero del Cura ◽  
Marta Drake Monfort ◽  
Adrian De Quintana Sancho ◽  
Marcos Antonio González López
Keyword(s):  
Botulinum Toxin ◽  
Negative Impact ◽  
Botulinum Toxin A ◽  
Psychosocial Burden ◽  
Toxin A ◽  
Rare Form ◽  
Good Safety Profile ◽  
Degree Of Satisfaction ◽  
Botulinum Toxin Injections

Perianal hyperhidrosis (HH) is a rare form of primary focal HH and may become a major problem for the patient with a significant psychosocial burden and negative impact on the quality of life. Botulinum toxin injections are widely used as a second-line treatment option for axillary, palmar, and plantar HH with a good safety profile. Herein, we pre­sent a case of primary perianal HH successfully treated with Botulinum toxin A at a dose higher than that previously reported in literature, with a longer response, a higher degree of satisfaction, and no adverse effects. Moreover, we review the main aspects of the perianal anatomy that are essential to carry out the technique correctly and make dermatologists achieve expertise with the procedure.

scholarly journals Predictors of Clinically Important Improvements in Motor Function and Daily Use of Affected Arm after a Botulinum Toxin A Injection in Patients with Chronic Stroke

Toxins ◽  
2021 ◽  
Vol 14 (1) ◽  
pp. 13
Author(s):  
Jen-Wen Hung ◽  
Wen-Chi Wu ◽  
Yi-Ju Chen ◽  
Ya-Ping Pong ◽  
Ku-Chou Chang
Keyword(s):  
Botulinum Toxin ◽  
Upper Extremity ◽  
Motor Function ◽  
Botulinum Toxin A ◽  
Change Score ◽  
Toxin A ◽  
Injection Duration ◽  
Active Motor ◽  
Quality Of Movement

Identifying patients who can gain minimal clinically important difference (MCID) in active motor function in the affected upper extremity (UE) after a botulinum toxin A (BoNT-A) injection for post-stroke spasticity is important. Eighty-eight participants received a BoNT-A injection in the affected UE. Two outcome measures, Fugl–Meyer Assessment Upper Extremity (FMA-UE) and Motor Activity Log (MAL), were assessed at pre-injection and after 24 rehabilitation sessions. We defined favorable response as an FMA-UE change score ≥5 or MAL change score ≥0.5.Statistical analysis revealed that the time since stroke less than 36 months (odds ratio (OR) = 4.902 (1.219–13.732); p = 0.023) was a significant predictor of gaining MCID in the FMA-UE. Medical Research Council scale -proximal UE (OR = 1.930 (1.004–3.710); p = 0.049) and post-injection duration (OR = 1.039 (1.006–1.074); p =0.021) were two significant predictors of MAL amount of use. The time since stroke less than 36 months (OR = 3.759 (1.149–12.292); p = 0.028), naivety to BoNT-A (OR = 3.322 (1.091–10.118); p = 0.035), and education years (OR = 1.282 (1.050–1.565); p = 0.015) were significant predictors of MAL quality of movement. The findings of our study can help optimize BoNT-A treatment planning.

Positiver Effekt von Botoxinjektionen auf Kopfschmerzen - willkommener Nebeneffekt, aber keine primäre Indikation

2018 ◽  
Vol 6 (3) ◽  
pp. 151-152
Author(s):  
Peter Arne Gerber
Keyword(s):  
Quality Of Life ◽  
Nervous System ◽  
Botulinum Toxin ◽  
Chronic Headache ◽  
Botulinum Toxin A ◽  
Toxin A ◽  
Beneficial Effects ◽  
Migraine Headaches ◽  
Tension Type Headaches

Background: Headache is a common disorder of the nervous system; chronic headache in particular may affect quality of life negatively. The pathophysiology is multifactorial and not completely elucidated. Studies have demonstrated the beneficial effects of botulinum toxin A on chronic migraine headaches, but failed to show the same effect on chronic tension-type headaches. Methods: We present the case of a 32-year-old woman who after receiving cosmetic injections with botulinum toxin A for fine lines of the forehead experienced relief of subclinical tension-type headaches. Conclusions: Although the effect of botulinum toxin A on chronic tension-type headaches is limited, several studies demonstrate its pain-modulating effects, and as such it is worth paying attention to this potential beneficial effect when performing cosmetic injections with botulinum toxin A.

scholarly journals Incidental Treatment of a Subclinical Chronic Tension-Type Headache by Cosmetic Use of Botulinum Toxin A: A Case Report

2017 ◽  
Vol 9 (3) ◽  
pp. 249-253
Author(s):  
Iselin Saltvig ◽  
Steen Henrik Matzen
Keyword(s):  
Botulinum Toxin ◽  
Chronic Headache ◽  
Botulinum Toxin A ◽  
Tension Type Headache ◽  
Toxin A ◽  
Beneficial Effects ◽  
Migraine Headaches ◽  
Type Headache ◽  
Tension Type Headaches

Background: Headache is a common disorder of the nervous system; chronic headache in particular may affect quality of life negatively. The pathophysiology is multifactorial and not completely elucidated. Studies have demonstrated the beneficial effects of botulinum toxin A on chronic migraine headaches, but failed to show the same effect on chronic tension-type headaches. Methods: We present the case of a 32-year-old woman who after receiving cosmetic injections with botulinum toxin A for fine lines of the forehead experienced relief of subclinical tension-type headaches. Conclusions: Although the effect of botulinum toxin A on chronic tension-type headaches is limited, several studies demonstrate its pain-modulating effects, and as such it is worth paying attention to this potential beneficial effect when performing cosmetic injections with botulinum toxin A.

Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity

2007 ◽  
Vol 41 (4) ◽  
pp. 335-340 ◽  
Author(s):  
Ingrid Ehren ◽  
Daniela Volz ◽  
Elisabeth Farrelly ◽  
Lena Berglund ◽  
Lou Brundin ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Botulinum Toxin ◽  
Detrusor Overactivity ◽  
Botulinum Toxin A ◽  
Neurogenic Detrusor Overactivity ◽  
Toxin A
Sign in / Sign up

Export Citation Format

Share Document